BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2007
View Archived Issues
Effects of 2R,4R-APDC reduced when given after seizure onset
Read More
Novel treatments for inflammatory disorders claimed in recent patent literature
Read More
Neuropeptide Y a therapeutic target for obesity
Read More
COG-1410 therapeutic in models of traumatic brain injury
Read More
Novartis highlights performance in first half of 2007
Read More
Acadia receives milestone payment for drug candidate for glaucoma
Read More
Update on Cook Medical's phase II trial of drug-coated stent
Read More
Affymax begins phase III trials of Hematide
Read More
Gruenenthal and Aventis sign licensing agreement for trimegestone
Read More
Novel agents for respiratory disorders claimed in recent Novartis, Novartis Pharma and Pfizer patent
Read More
Recent Astellas patent discloses novel treatment option for urological disorders
Read More
CS-917 fails to significantly lower placebo-adjusted HbA1c level in phase IIb study
Read More
Treatment begins in phase III trial of Litx for metastatic colorectal cancer
Read More
Orchestra Therapeutics discontinues HIV vaccine development program
Read More
ACZ-885 begins phase III for Muckle Wells syndrome
Read More
Pharmacopeia advances first therapeutic program with GSK
Read More
Banyu to change name to Merck-Banyu
Read More
Delay in data from phase III extension study of safinamide in early Parkinson's
Read More
Further encouraging phase II findings for ralfinamide in neuropathic pain
Read More
CDC adopts RotaTeq and Gardasil vaccination program
Read More
Update on Can-Fite's phase IIb study of methotrexate for RA
Read More
Positive results from Durect's phase IIb trial of Posidur for hernia repair pain
Read More
Avicena to begin confirmatory phase III trial of AL-02 for ALS
Read More
Seretide approved in Europe for broader COPD population
Read More
NDA submission for TMC-125
Read More
Cervarix recommended for approval in Europe and launched in Australia
Read More